Last updated: January 4, 2026
Sponsor: Asian Institute of Gastroenterology, India
Overall Status: Active - Recruiting
Phase
N/A
Condition
Gall Bladder Disorders
Treatment
N/AClinical Study ID
NCT07283185
EUS vs MRCP-CBD1
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥18 years
Intermediate likelihood of CBD stone (per ESGE)
Undergoing either MRCP or EUS for evaluation
Exclusion
Exclusion Criteria:
High or low likelihood category (per ESGE)
Undergoing both MRCP and EUS simultaneously
Contraindications to either modality
Study Design
Total Participants: 200
Study Start date:
December 01, 2025
Estimated Completion Date:
November 30, 2026
Study Description
Connect with a study center
AIG Hospitals
Hyderabad 1269843, Telangana 1254788 500032
IndiaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.